AZD1163 Placebo, AZD1163 clinical trials

A Multicentre, Parallel-group, Phase II, Randomised, Double-blind, 4 Arm Study to Evaluate Efficacy and Safety of AZD1163 in Participants with Moderately-to-Severely Active Rheumatoid Arthritis (LaunchPAD-RA)

This study is testing a new medicine, AZD1163, for people with moderate to severe rheumatoid arthritis. We want to see if it helps reduce joint pain and swelling, and if it's safe to use. Half the participants will receive the new medicine and half will receive a dummy medicine.